Results 251 to 260 of about 804,614 (310)

Yoga as a cost-effective adjunct therapy for dry eye: clinical outcomes from a 12-week randomized controlled trial. [PDF]

Front Med (Lausanne)
Abraham L, Bhat R, George S.
europepmc   +1 more source

Comparing the Effect of Semi‐Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio, Desiree Latella, Lilla Bonanno, Paulo Cezar Rocha dos Santos, Marcos Maldonado‐Díaz, Meir Plotnik, Rosaria De Luca, Angelo Quartarone, Rocco Salvatore Calabrò   +8 more
wiley   +1 more source

Ocular Toxicities of Anticancer Therapies in the Era of Precision Oncology: A Practical, Clinically Oriented Narrative Review. [PDF]

Biomedicines
Meriggi F, Oneda E, Cherri S, Petrelli F, Zaniboni A.   +4 more
europepmc   +1 more source

Hunting Firearm Induced Optic Nerve Transection. [PDF]

Int Med Case Rep J
Calabresi V, Cuccu A, Corda C, Giannaccare G.   +3 more
europepmc   +1 more source

Advances in ocular motor and pupil biomarkers for neurological disorders. [PDF]

Brain Commun
Coito A, Brügger D, Brémovà-Ertl T, Massatsch P, Abegg M, Weber KP, Salmen A.   +6 more
europepmc   +1 more source

Is Isolated Inferior Rectus Weakness a Strong Indicator for Myasthenia Gravis? [PDF]

Br Ir Orthopt J
Butterworth E, Choi J, Rhodes M, Simmons J.   +3 more
europepmc   +1 more source

Acral Lentiginous Melanoma With NRAS Mutation and Ocular Surface Toxicity Following Immunotherapy and Investigational KRASG12C Inhibitor: Case Report. [PDF]

Case Rep Oncol Med
Huynh E, Gregory A, Chang PY.
europepmc   +1 more source